Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Definitive screening for accelerated Taxol biosynthetic pathway optimization and scale up in Saccharomyces cerevisiae cell factories
  • +1
  • Laura Walls,
  • José Martinez,
  • E. Antonio del Rio Chanona,
  • Leonardo Rios Solis
Laura Walls
The University of Edinburgh School of Engineering

Corresponding Author:[email protected]

Author Profile
José Martinez
Technical University of Denmark
Author Profile
E. Antonio del Rio Chanona
Imperial College London Department of Chemical Engineering
Author Profile
Leonardo Rios Solis
The University of Edinburgh School of Engineering
Author Profile

Abstract

Recent technological advancements in synthetic and systems biology have enabled the construction of microbial cell factories expressing diverse heterologous pathways in unprecedentedly short time scales. However, the translation of such laboratory scale breakthroughs to industrial bioprocesses remains a major bottleneck. In this study, an accelerated bioprocess development approach was employed to optimize the biosynthetic pathway of the blockbuster chemotherapy drug, Taxol. Statistical design of experiments approaches were coupled with an industrially relevant high-throughput microbioreactor system to optimize production of key Taxol intermediates, Taxadien-5α-ol and Taxadien-5α-yl-acetate, in engineered yeast cell factories. The optimal factor combination was determined via data driven statistical modelling and validated in 1L bioreactors leading to a 2.1-fold improvement in taxane production compared to a typical defined media. Elucidation and mitigation of a nutrient limitation enhanced product titers a further two-fold and titers of the critical Taxol precursors, Taxadien-5α-ol and Taxadien-5α-yl-acetate were improved to 34 and 11 mg/L, representing a three-fold improvement compared to the highest literature titers in S. cerevisiae. Comparable titers were obtained when the process was scaled up a further five-fold using 5 L bioreactors. The results of this study highlight the benefits of a holistic design of experiments guided approach to expedite early stage bioprocess development.
04 Aug 2021Submitted to Biotechnology Journal
05 Aug 2021Submission Checks Completed
05 Aug 2021Assigned to Editor
05 Aug 2021Reviewer(s) Assigned
10 Sep 2021Editorial Decision: Revise Minor
23 Sep 20211st Revision Received
24 Sep 2021Submission Checks Completed
24 Sep 2021Assigned to Editor
24 Sep 2021Reviewer(s) Assigned
06 Oct 2021Editorial Decision: Revise Minor
08 Oct 20212nd Revision Received
10 Oct 2021Submission Checks Completed
10 Oct 2021Assigned to Editor
10 Oct 2021Reviewer(s) Assigned
11 Oct 2021Editorial Decision: Accept